ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial

Jeffrey A. Lieberman, Robert E. Davis, Christoph U. Correll, Donald C. Goff, John M. Kane, Carol A. Tamminga, Sharon Mates, Kimberly E. Vanover

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences